Antisense Therapeutics Pink Sheet Forecast - Simple Exponential Smoothing

ATHJF Stock  USD 0.04  0.00  0.00%   
The Simple Exponential Smoothing forecasted value of Antisense Therapeutics Limited on the next trading day is expected to be 0.04 with a mean absolute deviation of 0.001 and the sum of the absolute errors of 0.06. Antisense Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Antisense Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Antisense Therapeutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Antisense Therapeutics Limited are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Antisense Therapeutics prices get older.

Antisense Therapeutics Simple Exponential Smoothing Price Forecast For the 13th of December 2024

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Antisense Therapeutics Limited on the next trading day is expected to be 0.04 with a mean absolute deviation of 0.001, mean absolute percentage error of 0.000026, and the sum of the absolute errors of 0.06.
Please note that although there have been many attempts to predict Antisense Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Antisense Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Antisense Therapeutics Pink Sheet Forecast Pattern

Backtest Antisense TherapeuticsAntisense Therapeutics Price PredictionBuy or Sell Advice 

Antisense Therapeutics Forecasted Value

In the context of forecasting Antisense Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Antisense Therapeutics' downside and upside margins for the forecasting period are 0.0004 and 40.08, respectively. We have considered Antisense Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.04
0.0004
Downside
0.04
Expected Value
40.08
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Antisense Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Antisense Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria107.5587
BiasArithmetic mean of the errors -5.0E-4
MADMean absolute deviation0.001
MAPEMean absolute percentage error0.0196
SAESum of the absolute errors0.0592
This simple exponential smoothing model begins by setting Antisense Therapeutics Limited forecast for the second period equal to the observation of the first period. In other words, recent Antisense Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Antisense Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Antisense Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0440.08
Details
Intrinsic
Valuation
LowRealHigh
0.000.0440.08
Details

Other Forecasting Options for Antisense Therapeutics

For every potential investor in Antisense, whether a beginner or expert, Antisense Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Antisense Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Antisense. Basic forecasting techniques help filter out the noise by identifying Antisense Therapeutics' price trends.

Antisense Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Antisense Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Antisense Therapeutics could also be used in its relative valuation, which is a method of valuing Antisense Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Antisense Therapeutics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Antisense Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Antisense Therapeutics' current price.

Antisense Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Antisense Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Antisense Therapeutics shares will generate the highest return on investment. By undertsting and applying Antisense Therapeutics pink sheet market strength indicators, traders can identify Antisense Therapeutics Limited entry and exit signals to maximize returns.

Antisense Therapeutics Risk Indicators

The analysis of Antisense Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Antisense Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting antisense pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in Antisense Pink Sheet

Antisense Therapeutics financial ratios help investors to determine whether Antisense Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antisense with respect to the benefits of owning Antisense Therapeutics security.